Delivery Order SPE2DB22D2007-SPE2DB25FJ1YD
Award Date 5/30/25
Potential Completion Date 6/2/25
Potential Value $5.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,423.70 delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (10-unit dose packages) with a completion deadline of September 2, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a $5,909.37 delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (unit dose, 10 count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside award and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. UBRELVY (ubrogepant) is an acute migraine treatment medication, reflecting the Defense Logistics Agency's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,603.68 to AmerisourceBergen Drug Corp for UBRELVY 50 mg tablets (100 unit-dose packs) on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. UBRELVY (ubrogepant) is a prescription medication used for acute...
- The Defense Logistics Agency awarded a delivery order valued at $1,880.85 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (16 unit dose packs) on January 2, 2026, with a completion date of January 5, 2026. This is a firm fixed-price, non-set-aside delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $13,759.20 to AmerisourceBergen Drug Corp for the supply of UBRELVY (ubrogepant) 100 mg tablets in unit-dose packaging on September 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 17, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. UBRELVY is a migraine treatment medication,...
- The Defense Logistics Agency awarded a delivery order valued at $5,250.40 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets in unit dose packaging (10 tablets per unit). This competitive, non-set-aside contract was issued on January 14, 2026, with an ultimate completion date of January 15, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. UBRELVY (ubrogepant) is an acute migraine treatment medication, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $10,093.52 to AmerisourceBergen Drug Corp for the supply of UBRELVY (ubrogepant) 100 mg tablets in unit dose packaging on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. UBRELVY is an acute migraine treatment medication,...
- The Defense Logistics Agency awarded a $13.8K firm fixed-price delivery order to AmerisourceBergen Drug Corp for UBRELVY 50 mg tablets (10-count unit dose packaging) on May 30, 2025, with completion required by June 2, 2025. This non-competitive, non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999.99M through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 30, 2025, by the Defense Logistics Agency (DLA) for UBRELVY 100 MG tablets in unit dose packaging of 10 units, with a ceiling value of $1,009.99. This is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and represents a non-competitive procurement utilizing an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,270.92 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (10-count unit dose packaging) with an ultimate completion date of August 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open process. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. UBRELVY is a migraine treatment medication,...